Barclays PLC
OTC:BCLYF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Barclays PLC
OTC:BCLYF
|
UK |
|
M
|
MS&AD Insurance Group Holdings Inc
DUS:59M
|
JP |
|
Inpixon
NASDAQ:XTIA
|
US |
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
Accuray Inc
NASDAQ:ARAY
|
US |
|
D
|
Directa SIM SpA
F:ZP7
|
IT |
Wall St Price Targets
BCLYF Price Targets Summary
Barclays PLC
According to Wall Street analysts, the average 1-year price target for BCLYF is 7.58 USD with a low forecast of 6.29 USD and a high forecast of 9.05 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BCLYF's stock price target?
Price Target
7.58
USD
According to Wall Street analysts, the average 1-year price target for BCLYF is 7.58 USD with a low forecast of 6.29 USD and a high forecast of 9.05 USD.
What is the Revenue forecast for Barclays PLC?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 1%.
What is the Net Income forecast for Barclays PLC?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 3 years is 14%.
